Cargando…

Editorial: NK Cell-Based Cancer Immunotherapy

Detalles Bibliográficos
Autores principales:	Borrego, Francisco, Larrucea, Susana, Solana, Rafael, Tarazona, Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921465/ https://www.ncbi.nlm.nih.gov/pubmed/27446079 http://dx.doi.org/10.3389/fimmu.2016.00249

Ejemplares similares

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
por: Tarazona, Raquel, et al.
Publicado: (2016)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
por: Cifaldi, Loredana, et al.
Publicado: (2020)

Effect of CMV and Aging on the Differential Expression of CD300a, CD161, T-bet, and Eomes on NK Cell Subsets
por: Lopez-Sejas, Nelson, et al.
Publicado: (2016)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
por: Rodrigues-Santos, Paulo, et al.
Publicado: (2018)

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

NK Cell-Based Immunotherapy in Renal Cell Carcinoma
por: Terrén, Iñigo, et al.
Publicado: (2020)

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
por: Nersesian, Sarah, et al.
Publicado: (2019)

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
por: Shevtsov, Maxim, et al.
Publicado: (2016)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

The application of autologous cancer immunotherapies in the age of memory-NK cells
por: Lizana-Vasquez, Gaby D., et al.
Publicado: (2023)

Adaptive Memory of Human NK-like CD8(+) T-Cells to Aging, and Viral and Tumor Antigens
por: Pita-López, María Luisa, et al.
Publicado: (2016)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Prospects for NK-based immunotherapy of chronic HBV infection
por: Jin, Xiaomeng, et al.
Publicado: (2022)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
por: Tarannum, Mubin, et al.
Publicado: (2022)

Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
por: Carlsten, Mattias, et al.
Publicado: (2015)

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy
por: Wang, Wei, et al.
Publicado: (2015)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

NK Cell Metabolism and TGFβ – Implications for Immunotherapy
por: Slattery, Karen, et al.
Publicado: (2019)

Editorial: NK cell defects: diagnosis and treatment
por: Shabrish, Snehal, et al.
Publicado: (2023)

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
por: Terrén, Iñigo, et al.
Publicado: (2022)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
por: Carotta, Sebastian
Publicado: (2016)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Editorial: NK Cells in Human Diseases: Friends or Foes?
por: Vieillard, Vincent, et al.
Publicado: (2017)

Editorial: Molecular and Cellular Pathways in NK Cell Development
por: Sitnicka, Ewa, et al.
Publicado: (2020)

Editorial: Women in NK and innate lymphoid cell biology
por: Zingoni, Alessandra, et al.
Publicado: (2023)

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies
por: Jedlička, Marek, et al.
Publicado: (2022)

Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy
por: Chiang, Jason, et al.
Publicado: (2023)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8muokg4fdv9n2vhih4pgboha64